Clinical Trial Update: A Study of DCTY1102 Injection in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study of DCTY1102 Injection in patients with advanced solid tumors, including pancreatic ductal adenocarcinoma, colorectal cancer, non-small cell lung c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Non-small Cell Lung Cancer
• Pancreatic Ductal Adenocarcinoma
• Solid Tumors

Drugs mentioned

• DCTY1102 Injection

Snippet

Sponsor: Beijing DCTY Biotech Co.,Ltd. | Conditions: PDAC, CRC (Colorectal Cancer) | Phase 1 | Status: NOT_YET_RECRUITING